Their concentration differences were statistically significant in comparison to patients with simple steatosis (IL-4 and IL-17) or to both groups of noncirrhosis NAFLD (IFNγ) (Figure 1). This evidence concerns the gene IL4 and metabolic dysfunction-associated steatotic liver disease.